Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA (HAA, ALB, JB, XW, SJK); Department of Biostatistics, Brown University School of Public Health, Providence, Rhode Island, USA (JWH); The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA (JDR).
Send correspondence to Ashley Buchanan, DrPH, MS, Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, 7 Greenhouse Road, Suite 265A, Kingston, RI 02881, USA. E-mail: [email protected].
Received 2 January, 2019
Accepted 6 February, 2020
Earlier versions of this study were accepted for poster presentations at: The 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Prague, Czech Republic; August 22 to 26, 2018.
The Society for Epidemiologic Research (SER) Conference, Baltimore, MD; June 19 to 22, 2018.
Dr Rich was supported by grant number P20GM125507 and Drs. Buchanan and Kogut were partially supported by Institutional Development Award Number U54GM115677 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds Advance Clinical and Translational Research (Advance-CTR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
The authors have no conflicts of interest to disclose.
Conception and Design: HA, AB; Data Collection: HA, AB, SK; Data Analysis: HA, AB, SK; Data Interpretation: All; Manuscript Writing: All; Manuscript Revisions and Approval of Final Article: All.
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal's Web site (www.journaladdictionmedicine.com).
